| parkinson’s disease |
013 |
| safinamide |
013 |
| treatment. |
013 |
| parkinson hastalığı |
013 |
| safinamid |
013 |
| tedavi. |
013 |
| amyotrophic lateral sclerosis |
020 |
| ataxia |
020 |
| neurodegenerative diseases. |
020 |
| amyotrofik lateral skleroz |
020 |
| ataksi |
020 |
| nörodejeneratif hastalıklar. |
020 |
| constipation |
024 |
| levodopa |
024 |
| parkinson’s disease. |
024 |
| konstipasyon |
024 |
| parkinson hastalığı. |
024 |
| beta-ureidopropionase deficiency |
028 |
| deep brain stimulation |
028 |
| dystonia |
028 |
| holmes tremor. |
028 |
| beta-üreidopropionaz eksikliği |
028 |
| derin beyin stimülasyonu |
028 |
| distoni |
028 |
| holmes tremoru. |
028 |
| corticobasal degeneration |
031 |
| parkinsonian disorders |
031 |
| progressive supranuclear palsy |
031 |
| psp-cbs. |
031 |
| kortikobazal dejenerasyon |
031 |
| parkinsoniyen bozukluklar |
031 |
| progresif supranükleer palsi |
031 |
| psp-kbs. |
031 |
| cerebellitis |
036 |
| covid-19 |
036 |
| immunotherapy |
036 |
| intravenous immunoglobulin. |
036 |
| serebellit |
036 |
| immünoterapi |
036 |
| intravenöz immünoglobulin. |
036 |